Barinthus Biotherapeutics Corp (BRNS) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
R&D xarajatlarini qoplash uchun naqd zaxiralardan rejalashtirilgan foydalanish Barinthus Biotherapeutics (BRNS) uchun uzoq muddatli moliyaviy bog'liqlik koeffitsiyentini belgilovchi asosiy dinamika drayveri bo'lib xizmat qiladi. 0.14 qiymati ushbu ko'rsatkichning joriy miqdorini belgilaydi. Barinthus Biotherapeutics (BRNS) T-hujayralar terapiyasi orqali saraton vaksinalarini ishlab chiqadi va o'z intellektual mulkini sanoat gigantlariga patentlarni sotish orqali monetizatsiya qilib, kapital xarajatlarsiz royalti oqimini ta'minlaydi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261031&filename=GURU_Markets_-_BRNS_-_Barinthus-Biotherapeutics_-_Long-Term-Debt-to-Capital "BRNS: Barinthus Biotherapeutics plc Uzoq muddatli qarzning kapitalga nisbati 21.02.2024 - 19.09.2026 | 👁️GURU.Markets👁️")
Barinthus Biotherapeutics (BRNS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Barinthus Biotherapeutics|BRNS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati barinthusbio.com|BRNS - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Barinthus Biotherapeutics plc|BRNS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Barinthus Biotherapeutics|Tezkor likvidlik ko‘rsatkichi barinthusbio.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Barinthus Biotherapeutics PLC - BRNS
Barinthus Biotherapeutics (BRNS) kompaniyasi uchun, u barqaror biotexnologiya segmentida faoliyat yuritadi, ushbu ko'rsatkich kompaniyaning rivojlanishda qarz mablag'lariga qanchalik bog'liqligini belgilaydi. Ushbu metrika bir yildan ortiq muddatli majburiyatlarni sof kapital bilan solishtiradi. GURU.Markets uzoq muddatli qarzning kapitalga nisbati grafigidagi 0.14 ning joriy qiymati real moliyaviy barqarorlikni aks ettiradi. Past ko'rsatkich kompaniyaning makroiqtisodiy zarbalardan mustaqilligini tasdiqlaydi. Foiz stavkalari risklarini minimallashtirish uchun investorlarning ushbu balansni kuzatib borishi juda muhimdir.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|PVLA: Uzoq muddatli qarzning o'z kapitaliga nisbati|SVRA: Uzoq muddatli qarzning kapitalga nisbati|rigel.com (RIGL) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|ATXS: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ENGN|Uzoq muddatli qarzdorlikning kapitalga nisbati rapt.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Aerovate Therapeutics JBIO|ACRS: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|KYTX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Tiziana Life Sciences Ltd. - Uzoq muddatli kreditlarning kapitalga nisbati|CABA: Uzoq muddatli qarzning kapitalga nisbati|Ventyx Biosciences, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati THTX|Uzoq muddatli qarzning kapitalga nisbati avalotx.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Eledon Pharmaceuticals, Inc. (ELDN)|Uzoq muddatli qarzdorlikning kapitalga nisbati Agenus, Inc.|Climb Bio, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ZURA|aTyr Pharma, Inc. - Uzoq muddatli qarzning kapitalga nisbati|ADAG: Uzoq muddatli qarzning o'z kapitaliga nisbati|IMA: Uzoq muddatli qarzning kapitalga nisbati|STTK - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Equillium Inc|Uzoq muddatli majburiyatlarning kapitalga nisbati Connect Pharma CNTB|Uzoq muddatli qarzning o'z kapitaliga nisbati IMUX (Immunic, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati ATRA|Uzoq muddatli qarzning kapitalga nisbati IFRX (InflaRx)|Uzoq muddatli qarzning kapitalga koeffitsiyenti XFOR|Adicet - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Celularity Inc.|INmune Bio, Inc. (INMB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|kezarlifesciences.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SABS (SAB Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Akari Therapeutics PLC|Uzoq muddatli qarzning o'z kapitaliga nisbati Enlivex Therapeutics (ENLV)|QTTB: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|edesabiotech.com (EDSA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|IBIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|CARM - Uzoq muddatli qarzning kapitalga nisbati|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BOLT: Uzoq muddatli kreditlarning kapitalga nisbati|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Aptevo (APVO) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati AIM|Uzoq muddatli qarzning o'z kapitaliga nisbati aditxt.com ADTX|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|Uzoq muddatli qarzdorlikning kapitalga nisbati XORTX Corp (XRTX)|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|REVB: Uzoq muddatli qarzning o'z kapitaliga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Scinai Immunotherapeutics Ltd - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi AFMD (Affimed Therapeutics)|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|Uzoq muddatli qarzdorlikning kapitalga nisbati hookipapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|ITOS (iTeos Therapeutics Inc) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|THRD: Uzoq muddatli qarzning kapitalga nisbati